CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomised, Double-blind, Double-dummy, Multi-centre, Comparative Parallel-group Study to Evaluate the Efficacy of Oral Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in the Treatment of Acute Uncomplicated Diverticulitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01847664
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:29.818068+00:00
Published At: 2017-07-26T00:00:00+00:00
Record Updated At: 2017-07-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Uncomplicated Diverticulitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-07-26"
protocolSection.identificationModule.nctId: "NCT01847664"
protocolSection.identificationModule.officialTitle: "A Randomised, Double-blind, Double-dummy, Multi-centre, Comparative Parallel-group Study to Evaluate the Efficacy of Oral Rifamycin SV-MMX\u00ae 400 mg b.i.d. vs. Rifamycin SV-MMX\u00ae 600 mg t.i.d. vs. Placebo in the Treatment of Acute Uncomplicated Diverticulitis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.